<code id='50C74B12B6'></code><style id='50C74B12B6'></style>
    • <acronym id='50C74B12B6'></acronym>
      <center id='50C74B12B6'><center id='50C74B12B6'><tfoot id='50C74B12B6'></tfoot></center><abbr id='50C74B12B6'><dir id='50C74B12B6'><tfoot id='50C74B12B6'></tfoot><noframes id='50C74B12B6'>

    • <optgroup id='50C74B12B6'><strike id='50C74B12B6'><sup id='50C74B12B6'></sup></strike><code id='50C74B12B6'></code></optgroup>
        1. <b id='50C74B12B6'><label id='50C74B12B6'><select id='50C74B12B6'><dt id='50C74B12B6'><span id='50C74B12B6'></span></dt></select></label></b><u id='50C74B12B6'></u>
          <i id='50C74B12B6'><strike id='50C74B12B6'><tt id='50C74B12B6'><pre id='50C74B12B6'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:15381
          Lessons Learned
          Molly Ferguson for STAT

          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 

          Who we talked to:

          advertisement

          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Bristol 'take
          Bristol 'take

          MollyFerguson/STATSomeday-afterthoughtsonBristolMyersSquibbacquiringMiratiTherapeutics:Atake-underde

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          When a patient nears the end, a feared therapy can comfort

          ArmellaLeungforSTATItwasmid-October2008whenthemedicsrolledtheelderlymanthroughtheglass-enclosedlobby